Literature DB >> 36264984

Neighbourhood-level socio-demographic characteristics and risk of COVID-19 incidence and mortality in Ontario, Canada: A population-based study.

Trevor van Ingen1, Kevin A Brown1,2,3, Sarah A Buchan1,2,3, Samantha Akingbola1, Nick Daneman1,2,4,5,6, Christine M Warren1, Brendan T Smith1,3.   

Abstract

OBJECTIVES: We aimed to estimate associations between COVID-19 incidence and mortality with neighbourhood-level immigration, race, housing, and socio-economic characteristics.
METHODS: We conducted a population-based study of 28,808 COVID-19 cases in the provincial reportable infectious disease surveillance systems (Public Health Case and Contact Management System) which includes all known COVID-19 infections and deaths from Ontario, Canada reported between January 23, 2020 and July 28, 2020. Residents of congregate settings, Indigenous communities living on reserves or small neighbourhoods with populations <1,000 were excluded. Comparing neighbourhoods in the 90th to the 10th percentiles of socio-demographic characteristics, we estimated the associations between 18 neighbourhood-level measures of immigration, race, housing and socio-economic characteristics and COVID-19 incidence and mortality using Poisson generalized linear mixed models.
RESULTS: Neighbourhoods with the highest proportion of immigrants (relative risk (RR): 4.0, 95%CI:3.5-4.5) and visible minority residents (RR: 3.3, 95%CI:2.9-3.7) showed the strongest association with COVID-19 incidence in adjusted models. Among individual race groups, COVID-19 incidence was highest among neighbourhoods with the high proportions of Black (RR: 2.4, 95%CI:2.2-2.6), South Asian (RR: 1.9, 95%CI:1.8-2.1), Latin American (RR: 1.8, 95%CI:1.6-2.0) and Middle Eastern (RR: 1.2, 95%CI:1.1-1.3) residents. Neighbourhoods with the highest average household size (RR: 1.9, 95%CI:1.7-2.1), proportion of multigenerational families (RR: 1.8, 95%CI:1.7-2.0) and unsuitably crowded housing (RR: 2.1, 95%CI:2.0-2.3) were associated with COVID-19 incidence. Neighbourhoods with the highest proportion of residents with less than high school education (RR: 1.6, 95%CI:1.4-1.8), low income (RR: 1.4, 95%CI:1.2-1.5) and unaffordable housing (RR: 1.6, 95%CI:1.4-1.8) were associated with COVID-19 incidence. Similar inequities were observed across neighbourhood-level sociodemographic characteristics and COVID-19 mortality.
CONCLUSIONS: Neighbourhood-level inequities in COVID-19 incidence and mortality were observed in Ontario, with excess burden experienced in neighbourhoods with a higher proportion of immigrants, racialized populations, large households and low socio-economic status.

Entities:  

Mesh:

Year:  2022        PMID: 36264984      PMCID: PMC9584389          DOI: 10.1371/journal.pone.0276507

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


  27 in total

Review 1.  Measurement of socioeconomic status in health disparities research.

Authors:  Vickie L Shavers
Journal:  J Natl Med Assoc       Date:  2007-09       Impact factor: 1.798

2.  Using observation-level random effects to model overdispersion in count data in ecology and evolution.

Authors:  Xavier A Harrison
Journal:  PeerJ       Date:  2014-10-09       Impact factor: 2.984

3.  Assessment of Community-Level Disparities in Coronavirus Disease 2019 (COVID-19) Infections and Deaths in Large US Metropolitan Areas.

Authors:  Samrachana Adhikari; Nicholas P Pantaleo; Justin M Feldman; Olugbenga Ogedegbe; Lorna Thorpe; Andrea B Troxel
Journal:  JAMA Netw Open       Date:  2020-07-01

4.  Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities.

Authors:  Tony Kirby
Journal:  Lancet Respir Med       Date:  2020-05-10       Impact factor: 30.700

5.  What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors.

Authors:  Wee Chian Koh; Lin Naing; Liling Chaw; Muhammad Ali Rosledzana; Mohammad Fathi Alikhan; Sirajul Adli Jamaludin; Faezah Amin; Asiah Omar; Alia Shazli; Matthew Griffith; Roberta Pastore; Justin Wong
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

6.  Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study.

Authors:  Maria E Sundaram; Andrew Calzavara; Sharmistha Mishra; Rafal Kustra; Adrienne K Chan; Mackenzie A Hamilton; Mohamed Djebli; Laura C Rosella; Tristan Watson; Hong Chen; Branson Chen; Stefan D Baral; Jeffrey C Kwong
Journal:  CMAJ       Date:  2021-04-27       Impact factor: 8.262

7.  Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.

Authors:  Shirley Sze; Daniel Pan; Clareece R Nevill; Laura J Gray; Christopher A Martin; Joshua Nazareth; Jatinder S Minhas; Pip Divall; Kamlesh Khunti; Keith R Abrams; Laura B Nellums; Manish Pareek
Journal:  EClinicalMedicine       Date:  2020-11-12

8.  Temporal trends in cardiovascular disease risk factors among white, South Asian, Chinese and black groups in Ontario, Canada, 2001 to 2012: a population-based study.

Authors:  Maria Chiu; Laura C Maclagan; Jack V Tu; Baiju R Shah
Journal:  BMJ Open       Date:  2015-08-10       Impact factor: 2.692

9.  US-county level variation in intersecting individual, household and community characteristics relevant to COVID-19 and planning an equitable response: a cross-sectional analysis.

Authors:  Taylor Chin; Rebecca Kahn; Ruoran Li; Jarvis T Chen; Nancy Krieger; Caroline O Buckee; Satchit Balsari; Mathew V Kiang
Journal:  BMJ Open       Date:  2020-09-01       Impact factor: 2.692

10.  Social Determinants of COVID-19 in Massachusetts, United States: An Ecological Study.

Authors:  Devan Hawkins
Journal:  J Prev Med Public Health       Date:  2020-06-24
View more
  1 in total

1.  Population-weighted exposure to green spaces tied to lower COVID-19 mortality rates: A nationwide dose-response study in the USA.

Authors:  Yuwen Yang; Yi Lu; Bin Jiang
Journal:  Sci Total Environ       Date:  2022-08-28       Impact factor: 10.753

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.